Minnesota Governor Tim Walz sharply criticized Elon Musk after a New York Times report alleged that the tech mogul had been using ketamine daily during the 2024 presidential campaign. Speaking at the Democratic state convention in South Carolina, Walz questioned why Musk wasn’t facing drug tests, despite political figures proposing stricter regulations for welfare recipients. Musk has denied the claims, but the controversy surrounding his personal life continues to spark debate. Will Musk’s actions affect his business empire? The scrutiny over his habits is growing.

Minnesota Governor Tim Walz Takes Aim at Elon Musk Amid Ketamine Reports

In a biting remark aimed at Elon Musk, Minnesota Governor Tim Walz slammed the tech mogul following allegations that Musk had frequently used ketamine during the 2024 presidential election campaign. The controversy surrounding Musk’s alleged drug use became a hot topic after a New York Times report linked the billionaire to daily ketamine use, as he campaigned in support of former President Donald Trump.

Walz’s Scathing Critique at Democratic Convention

At a Democratic state convention in South Carolina on Saturday, Walz took the opportunity to criticize Musk, although he started his comments with a bit of an unexpected concession. “I want to give Elon a little bit of credit. I know you’re finding that hard to believe,” Walz said, before delivering a pointed jab: “Somebody said, ‘Do you think he does anything right?’ Yes, this week, he did. He finally quit and found government waste.”

Walz’s comments were a direct response to Musk’s growing controversy over his reported use of ketamine and his continued involvement in the political arena. The governor followed up with criticism of proposed policies, including drug tests for individuals on Supplemental Nutrition Assistance Program (SNAP) benefits. “Isn’t it funny that they want to drug test SNAP recipients but not that dude? Just saying,” Walz quipped, implying that Musk’s personal issues with drug use were being overlooked despite political leaders proposing stricter regulations for those receiving welfare benefits.

The New York Times Report: Ketamine Use Allegations

The New York Times report that broke the story of Musk’s alleged ketamine use sent shockwaves through both the political and business communities. According to the report, Musk reportedly used the drug as frequently as once a day during the 2024 presidential campaign. Musk himself has confirmed he has taken prescription ketamine in the past, claiming that it helped him manage depression, but denied the daily use suggested in the report.

Musk’s self-reported use of ketamine—coupled with his past admissions of using ecstasy and other drugs—has raised eyebrows among some of his closest business associates, who fear it could harm his companies. These companies, including Tesla, SpaceX, and his social media platform X, are worth billions of dollars, and some worry that Musk’s personal behavior could spill over into his professional life, especially given his significant influence over such major ventures.

Musk’s Public Denial and Dismissal of the Report

Despite the allegations, Musk has publicly denied the New York Times report, responding dismissively when asked about his drug use during a press conference on Friday. “The New York Times? Is that the same publication that got a Pulitzer Prize for false reporting on Russiagate?” Musk shot back, cutting off a reporter’s question before moving on.

On Saturday, Musk took to X (formerly Twitter) to further clarify his stance, stating, “I’m NOT taking drugs” and acknowledging that he “tried prescription ketamine a few years ago” but had not taken it since. His denial was a direct rebuttal to the report, but questions about the impact of his personal habits on his professional life lingered.

Concerns Over Impact on Business

Musk’s alleged ketamine use has raised concerns not just among journalists and political commentators, but also within the tech and business world. Reports from The Wall Street Journal last year suggested that some of Musk’s associates were worried that his drug use, coupled with his erratic public behavior, could hurt his business ventures. However, Musk himself has brushed off these concerns, insisting that “what matters is execution” and that he can still perform at the highest level despite his personal habits.

While Musk continues to maintain that his drug use does not interfere with his work, the New York Times report has nonetheless added fuel to a growing debate about the role of personal conduct in leadership positions, especially for someone with as much power and influence as Musk.

Conclusion: A Growing Debate Over Personal Behavior and Public Accountability

The drama surrounding Elon Musk and his alleged ketamine use is far from over. While Musk has vehemently denied the most serious allegations, the fact that such reports continue to surface only adds to the ongoing scrutiny of his personal life and its potential impact on his business empire. For political figures like Tim Walz, Musk’s behavior raises questions about accountability, especially when it comes to leaders in the public and private sectors.

Musk, with his extensive global influence and role in shaping modern technology and politics, is a highly controversial figure. But as the debate continues, one thing is clear: Musk’s personal habits are now a central part of the conversation, and the public is watching closely to see whether his behavior will affect his companies and his public image moving forward.